Ascend Wellness Holdings (AAWH) Total Debt Growth (1y) (2021 - 2026)
Ascend Wellness Holdings (AAWH) Total Debt Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 41.53% |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | 2.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.89% |
| Mar 31, 2026 | -9.29% |
| Dec 31, 2025 | -13.35% |
| Sep 30, 2025 | 20.64% |
| Jun 30, 2025 | 13.03% |
| Mar 31, 2025 | 7.25% |
| Dec 31, 2024 | 24.55% |
| Sep 30, 2024 | -0.49% |
| Jun 30, 2024 | -0.16% |
| Mar 31, 2024 | -4.17% |
| Dec 31, 2023 | -7.55% |
| Sep 30, 2023 | -0.97% |
| Jun 30, 2023 | 5.63% |
| Mar 31, 2023 | 38.66% |
| Dec 31, 2022 | 27.76% |
| Sep 30, 2022 | 21.47% |
| Jun 30, 2022 | 127.73% |
| Mar 31, 2022 | -6.23% |
| Dec 31, 2021 | 22.30% |